Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development.

Saved in:
Bibliographic Details
Title: Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development.
Authors: Files MA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, USA., Hansen CA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA., Herrera VC; Department of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston, TX, USA.; Office of Public Health Outbreak Coordination, Informatics & Surveillance, Division of Disease Control and Health Statistics, Washington State Department of Health, Shoreline, WA, USA., Schindewolf C; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Barrett ADT; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA. abarrett@utmb.edu.; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA. abarrett@utmb.edu.; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. abarrett@utmb.edu.; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA. abarrett@utmb.edu., Beasley DWC; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA.; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX, USA., Bourne N; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA.; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.; Division of Vaccinology, Department of Pediatrics, University of Texas Medical Branch, Galveston, TX, USA., Milligan GN; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA.; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.; Division of Vaccinology, Department of Pediatrics, University of Texas Medical Branch, Galveston, TX, USA.
Source: NPJ vaccines [NPJ Vaccines] 2022 Mar 17; Vol. 7 (1), pp. 38. Date of Electronic Publication: 2022 Mar 17.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-0105
DOI:10.1038/s41541-022-00456-2